- Home
- ASYS vs QNCX Comparison
ASYS vs QNCX Comparison
Compare ASYS & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASYS
- QNCX
- Stock Information
- Founded
- ASYS 1981
- QNCX 2012
- Country
- ASYS United States
- QNCX United States
- Employees
- ASYS N/A
- QNCX N/A
- Industry
- ASYS Industrial Machinery/Components
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASYS Technology
- QNCX Health Care
- Exchange
- ASYS Nasdaq
- QNCX Nasdaq
- Market Cap
- ASYS 83.0M
- QNCX 88.6M
- IPO Year
- ASYS N/A
- QNCX 2019
- Fundamental
- Price
- ASYS $7.20
- QNCX $1.60
- Analyst Decision
- ASYS
- QNCX Strong Buy
- Analyst Count
- ASYS 0
- QNCX 6
- Target Price
- ASYS N/A
- QNCX $8.00
- AVG Volume (30 Days)
- ASYS 249.3K
- QNCX 271.4K
- Earning Date
- ASYS 12-08-2025
- QNCX 11-12-2025
- Dividend Yield
- ASYS N/A
- QNCX N/A
- EPS Growth
- ASYS N/A
- QNCX N/A
- EPS
- ASYS N/A
- QNCX N/A
- Revenue
- ASYS $83,634,000.00
- QNCX N/A
- Revenue This Year
- ASYS N/A
- QNCX N/A
- Revenue Next Year
- ASYS $12.93
- QNCX N/A
- P/E Ratio
- ASYS N/A
- QNCX N/A
- Revenue Growth
- ASYS N/A
- QNCX N/A
- 52 Week Low
- ASYS $3.20
- QNCX $0.72
- 52 Week High
- ASYS $10.80
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- ASYS 39.43
- QNCX 37.36
- Support Level
- ASYS $7.80
- QNCX $1.76
- Resistance Level
- ASYS $8.46
- QNCX $1.88
- Average True Range (ATR)
- ASYS 0.45
- QNCX 0.10
- MACD
- ASYS -0.09
- QNCX -0.03
- Stochastic Oscillator
- ASYS 3.38
- QNCX 9.28
About ASYS Amtech Systems Inc.
Amtech Systems Inc is a manufacturer of capital equipment, including thermal processing and wafer polishing, and related consumables used in fabricating semiconductor devices, such as silicon carbide (SiC) and silicon power chips, electronic assemblies, and light-emitting diodes (LEDs). the company has two segments; based on the industries served: Thermal Processing Solutions (formerly called Semiconductor) and Semiconductor Fabrication Solutions (formerly called Material and Substrate). Maximum revenue is generated from Thermal Processing Solutions. Maximum revenue is from Asia Region.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.